Mode
Text Size
Log in / Sign up
N/A N=29 Treatment

Electronic Cigarette Use in Young Adult Men and Women

Cigarette Smoking · Tobacco Use

Enrolled (actual)
29
Serious AEs
0.0%
Results posted
May 2023
Primary outcome: Primary: Contextual Factors Associated With Tobacco Use Episode Reported Via Ecological Momentary Assessment — 3; 22; 11; 12 tobacco use episodes — p=0.002

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Survey Arm (Behavioral)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Yale University
Primary completion
Oct 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Contextual Factors Associated With Tobacco Use Episode Reported Via Ecological Momentary Assessment
3; 22; 11; 12; 5; 3 0.002 sig

Summary

This one-year pilot study of 30 non-treatment seeking young adult e-cigarette/combustible tobacco product dual users (15 males/15 females) will use smartphone-based ecological momentary assessment (EMA) to gather real-time data of e-cigarette and combustible tobacco product behaviors during a 1-week cigarette/e-cigarette dual use period .(1) Participants will respond to daily random prompts assessing in-the-moment use of e-cigarettes/cigarettes and the subjective factors (ratings of satisfaction and withdrawal) and contextual factors (location, activity, social cues) associated with each episode of use. Participants will also complete daily electronic diaries to document e-cigarette use episodes/day, and satisfaction with the e-cigarette experience during the study.

Eligibility Criteria

Inclusion Criteria

  • be 18 through 29 years of age;
  • Smoke cigarettes;
  • have experience with e-cigarette use;
  • fluent in English;
  • have a functioning cell phone for personal use ;
  • have access to wireless networks at least once daily;
  • have self-reported good health.

Exclusion Criteria.

  • report serious medical illness;
  • are women who are currently/planning to be pregnant or breastfeeding.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03089541). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search